INVO Fertility, Inc. Deferred Revenue, Revenue Recognized
INVO Fertility, Inc. (IVF) reported Deferred Revenue, Revenue Recognized of $3.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2026-08-14
- INVO Fertility, Inc. deferred revenue, revenue recognized for the quarter ending 2026-03-31 was $1.89M.
- INVO Fertility, Inc. deferred revenue, revenue recognized for the quarter ending 2020-09-30 was $178.57K, a 0.00% increase year-over-year.
- INVO Fertility, Inc. deferred revenue, revenue recognized for the quarter ending 2020-06-30 was $178.57K.
- INVO Fertility, Inc. deferred revenue, revenue recognized for the quarter ending 2019-09-30 was $178.57K.
- INVO Fertility, Inc. deferred revenue, revenue recognized for fiscal 2025 was $6.95M, a 2.32% increase from fiscal 2024.
- INVO Fertility, Inc. deferred revenue, revenue recognized for fiscal 2024 was $6.80M.
| Period end | Deferred Revenue, Revenue Recognized 3 month | Deferred Revenue, Revenue Recognized 6 month | Deferred Revenue, Revenue Recognized 9 month | Deferred Revenue, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.69M 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | $1.89M 10-Q · filed 2026-06-22 | |||
| 2025-12-31 | $6.95M 10-K · filed 2026-06-02 | |||
| 2024-12-31 | $6.80M 10-K · filed 2026-06-02 | |||
| 2020-09-30 | $178.57K 10-Q · filed 2020-11-16 | $357.14K 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | $178.57K 10-Q · filed 2020-08-13 | $357.14K 10-Q · filed 2020-08-13 | ||
| 2019-09-30 | $178.57K 10-Q · filed 2019-11-14 | $535.71K 10-Q · filed 2019-11-14 | ||
| 2019-06-30 | $178.57K 10-Q · filed 2019-08-14 | |||
| 2019-03-31 | $178.57K 10-Q · filed 2019-05-15 | |||
| 2018-06-30 | $357.14K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |